Wednesday, 22 April 2015

Penny stocks - 5 things you must know before investing


Penny Stocks are those which trade at very low price and has a low market capitalization. While there is no simple definition, penny stocks in India generally trade at Rs 0.05 to Rs 10 per share. Individuals invest in these penny stocks and lose money as their share price is highly fluctuating. What should an investor know before investing in Penny Stocks in India?

5 things you must know before investing in penny stocks in India

1) Don’t look at the share price, but look at the value: Penny stocks are available at a relatively low share price. Share price would tempt investors to buy in such stocks. For example, Infosys stock price is Rs 2,180 per share. On the other hand, one of the penny stocks like GV Films is Rs 0.58 per share. Now if you have Rs 10,000 to invest, you would get only 4 Infosys Shares, while on the other hand you would get 17,240 shares of GV Films. Here one should not think how many shares they are getting, but what value these stocks offer.  I am not saying this penny stock is good or bad, but an investor should assess how good such a stock is before investing in such stocks.

2) Low volumes means low liquidity: Several Penny stocks generally trade at low volume. Means if you want to sell and come out, there might not be any buyers.  Hence invest in penny stocks that has high volume so that you can liquidate if required. E.g. Odyssey Corp share price is Rs 4.23 and avg trading volume is 24,200 shares only. The maximum amount traded is only Rs 1 Lakh. Such stocks have less liquidity as it would depend on demand from buyers.  

3) Upper circuit and lower circuits: Penny stocks have upper circuit and lower circuit. Upper circuit means a stock price cannot increase beyond a pre-determined percentage move. Generally it would be 5% to 10%. Lower circuit on the other hand means a stock price cannot reduce by specified percentage. As an investor, you should know that you cannot double your money in a short span, just because a stock has locked in upper circuit for couple of days. Penny stocks may see upper circuit for a few days and can see the lower circuit by few days based on demand from buyers.

4) Brokers / Promoters can manipulate share prices: Since penny stocks have low volume, share prices for such stocks can be easily manipulated by market participants, stock brokers or promoters of the company. If a penny stock price is reaching upper circuit every day without any news about the company, it clearly indicates that someone is manipulating the share price. As an investor if you hear a positive news about the company and think the future prospects are good, you can invest in a company irrespective whether it is hitting upper circuit or not.

5) Ignore success stories: Many stock brokers, websites, blogs, etc. indicate a success story about penny stocks. While these look good, no one want to talk about hidden stories about investors losing money on penny stocks. Many brokers charge high fees, giving penny stock recommendations indicating a success story saying a penny stock raised by 100% or 500%. Investors fall for that trap, invests and loses money. As an investor, you should understand why a penny stock price has gone up, the reasons behind that and future prospects. If you are convinced by this, you can adopt similar strategies for other penny stocks and invest based on such strategies. 

Indian market expensive, but a better bet than Brazil

Brokerage firm Credit Suisse has maintained its 10 percent overweight stance on India, buoyed by economic recovery and a significant fall in inflation. Credit Suisse believes Prime Minister Narendra Modi's structural economic reform programme is already bearing fruit and India merits an exclusion from the 'fragile five.' 

Some concerns notwithstanding, the brokerage says it prefers India over Brazil in the emerging markets (EMs) space. "Our MSCI India regression model suggests the greatest potential upside in global emerging markets (GEM)," says the report, However the report added that the negative top and bottom line revisions is making the firm nervous about maintaining the 'overweight' call.

YES Bank Q4 profit seen up 28% to Rs 549 cr on other income

According to a CNBC-TV18 poll, profit is estimated at Rs 549 crore during March quarter, a growth of 27.6 percent over same quarter last year, supported by other income. Net interest income, the difference between interest earned and interest expended, may jump 32 percent to Rs 950 crore in fourth quarter of financial year 2014-15 from Rs 720 crore in same quarter last year. 

The growth in NII may also be supported by low base in Q4FY14 when NII had increased 13 percent to Rs 720 crore. Analysts feel the growth in other income may be led by financial advisory, third party distribution and trading gains. 

Continued support from operating profit will also be closely watched. In Q3FY15, other income spiked 38 percent Y-o-Y to Rs 536.81 crore and operating profit grew by 40 percent to Rs 862.73 crore. 

Asset quality is the key parameter to watch out for in Q4 as in previous quarter (Q3) saw 25 percent spike in gross non-performing assets (NPA) and 20 percent rise in net NPAs. Analysts see restructuring rising on sequential basis while loan growth may be above industry average, which may be around 25 percent against 30 percent each in previous two quarters.

Thursday, 16 April 2015

Deepak Fertilisers sells 5.2% stake in MCFL

Continuing its exit from the Vijay Mallya-led UB Group firm, Deepak Fertilisers on Wednesday sold another 5.2 percent stake in Mangalore Chemicals and Fertilizers Ltd for over Rs 53 crore. Pune-based Deepak Fertilisers has been competing with industrialist Saroj Poddar-led Zuari group for taking control of the MCFL since July 2013. Deepak Fertilisers had offloaded 12.1 percent stake in MCFL on Monday. 

According to the bulk deal information with stock exchanges today, it sold 61.41 lakh shares (representing 5.2 percent stake) of MCFL. The company held MCFL shares through its subsidiary SCM Soilfert Ltd. Individually, Deepak Fertilisers sold 40.91 lakh shares on the NSE and 20.50 lakh on the BSE. The company's shares were sold at an average price of Rs 87.04 apiece, valuing the transaction at Rs 53.45 crore. 

At the end of December quarter, 2014, SCM Soilfert held 3.44 crore shares in MCFL, representing 29.05 percent stake in the company. In January, it had sold 2.2 percent stake in MCFL. The move follows Zuari Group's announcing the launch of its open offer on April 20 to acquire additional a 36.56 percent stake in MCFL. As of December 2014, Zuari had 16.47 percent stake in MCFL. 

Deepak Fert stock price 
On April 16, 2015, at 12:13 hrs Deepak Fertilizers and Petrochemicals Coprn was quoting at Rs 148.75, up Rs 0.50, or 0.34 percent. The 52-week high of the share was Rs 185.05 and the 52-week low was Rs 116.30. The company's trailing 12-month (TTM) EPS was at Rs 16.16 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 9.2. The latest book value of the company is Rs 169.05 per share. At current value, the price-to-book value of the company is 0.88.

Stocks in news: TCS, Bharti, Nestle, Tech Mah, Eicher Motor

TCS | Bharti Airtel | Coal India | Nestle India | Tech Mahindra | Eicher Motors | Financial Technologies | Gammon India | Sun Pharma | DLF | Mangalore Chemicals | Deepak Fertilisers and JSPL are stocks, which are in the news today.

Results Today: TCS , IndusInd Bank , Mindtree , Gruh Finance

Wednesday, 1 April 2015

Dr Reddy's up 2%, buys part of Belgium co's India

Shares of Dr Reddy's Laboratories gained more than 2 percent intraday Wednesday on acquisition of select portfolio of the established products business of Belgium-based pharma company in India. "Dr Reddy's Labs today has entered into a definitive agreement to acquire a select portfolio of the established products business of UCB, in the territories of India, Nepal, Sri Lanka and Maldives, for Rs 800 crore (euro 118 million)," said the company in its filing to the exchange. 

The acquired business is being sold on a slump sale basis, it added. The transaction included approximately 350 employees engaged in operations of the India business. The revenues of the acquired business were approximately Rs 150 crore for the calendar year 2014. The acquisition of UCB's existing brand equity in the areas of dermatology, respiratory and pediatrics diseases will further expand Dr Reddy's therapy footprint into these fast growing areas. 

"The acquired UCB portfolio shall accelerate Dr Reddy's presence in the high growth areas of dermatology, respiratory and pediatrics with market leading brands like Atarax, Nootropil, Zyrtec, Xyzal, Zyzal M etc," said Alok Sonig, senior vice president and India business head. The transaction is expected to be closed in the first quarter of the current financial year 2015-16.

Tuesday, 17 February 2015

List of Holidays 2015


SI.NO.HolidaysDateDay
1Republic DayJanuary 26, 2015Monday
3MahashivratriFebruary 17,2015Tuesday
2Chhatrapati Shivaji Maharaj Jayanti *February 19, 2015Thursday
4HoliMarch 06,2015Friday
5Annual Bank Closing*April 01,2015Wednesday
6Mahavir JayantiApril 02,2015Thursday
7Good FridayApril 03,2015Friday
8Dr.Baba Saheb Ambedkar JayantiApril 14,2015Tuesday
9Maharashtra DayMay 01,2015Friday
10Buddha Pournima*May 04,2015Monday
11Parsi New Year*August 18,2015Tuesday
12Ganesh ChaturthiSeptember 17,2015Thursday
13Bakri IdSeptember 25,2015Friday
14Mahatma Gandhi JayanthiOctober 02,2015Friday
15DussehraOctober 22,2015Thursday
16Diwali * Laxmi PujanNovember 11,2015Wednesday
17Diwali BalipratipadaNovember 12,2015Thursday
18Gurunanak JayantiNovember 25,2015Wednesday
19Id-e-MiladDecember 24,2015Thursday
20ChristmasDecember 25,2015Friday